ABBOTT LABORATORIES - Common Stock (ABT)

Historical Holders from Q1 2014 to Q3 2025

Symbol
ABT on NYSE
CUSIP
002824100
Type / Class
Equity / Common Stock
Shares outstanding
1.74B
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
1.35B
Holdings value
$181B
% of all portfolios
0.143%
Grand Portfolio weight change
-0.004%
Number of holders
3112
Number of buys
1308
Number of sells
-1431
Average Value change %
0%
Average buys %
+0.009%
Average sells %
-0.012%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ABBOTT LABORATORIES - Common Stock (ABT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 10.05% $22.2B 175M The Vanguard Group Nov 28, 2025

Institutional Holders of ABBOTT LABORATORIES - Common Stock (ABT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1.35B $181B -$2.76B $133.94 3,112
2025 Q2 1.37B $186B +$3.61B $136.01 3,146
2025 Q1 1.35B $179B +$454M $132.65 3,118
2024 Q4 1.34B $152B +$6.82B $113.11 3,004
2024 Q3 1.28B $146B -$4.17B $114.01 2,856
2024 Q2 1.32B $137B +$3.83B $103.91 2,818
2024 Q1 1.29B $146B -$1.94B $113.66 2,844
2023 Q4 1.3B $143B +$3.18B $110.07 2,819
2023 Q3 1.27B $123B -$2.51B $96.85 2,627
2023 Q2 1.3B $141B -$216M $109.02 2,689
2023 Q1 1.3B $131B +$417M $101.26 2,661
2022 Q4 1.29B $142B -$57.2M $109.79 2,730
2022 Q3 1.29B $125B +$155M $96.76 2,577
2022 Q2 1.29B $140B +$1.36B $108.65 2,654
2022 Q1 1.28B $152B -$1.33B $118.36 2,721
2021 Q4 1.29B $182B -$1.05B $140.74 2,778
2021 Q3 1.3B $153B -$385M $118.13 2,504
2021 Q2 1.3B $151B -$1.56B $115.93 2,476
2021 Q1 1.31B $157B +$1.61B $119.84 2,498
2020 Q4 1.31B $143B +$313M $109.49 2,458
2020 Q3 1.3B $142B -$17.8M $108.83 2,289
2020 Q2 1.3B $119B -$1.44B $91.43 2,227
2020 Q1 1.32B $104B -$487M $78.91 2,110
2019 Q4 1.32B $115B +$585M $86.86 2,177
2019 Q3 1.32B $110B -$178M $83.67 2,019
2019 Q2 1.32B $111B +$1.87B $84.10 2,007
2019 Q1 1.31B $105B -$633M $79.94 1,994
2018 Q4 1.32B $95.6B +$1.9B $72.33 1,967
2018 Q3 1.29B $94.8B +$2.99B $73.36 1,864
2018 Q2 1.25B $76.5B -$962M $60.99 1,801
2018 Q1 1.27B $76.3B +$367M $59.92 1,798
2017 Q4 1.27B $72.3B -$432M $57.07 1,751
2017 Q3 1.27B $67.9B +$614M $53.36 1,598
2017 Q2 1.26B $61.4B +$808M $48.61 1,576
2017 Q1 1.25B $55.6B +$10.5B $44.41 1,588
2016 Q4 1.11B $42.5B +$408M $38.41 1,517
2016 Q3 1.09B $46.1B +$1.15B $42.29 1,482
2016 Q2 1.07B $42B +$1.7B $39.31 1,466
2016 Q1 1.02B $42.8B -$177M $41.83 1,455
2015 Q4 1.03B $46.2B -$497M $44.91 1,497
2015 Q3 1.04B $41.8B +$279M $40.22 1,458
2015 Q2 1.03B $50.7B +$296M $49.08 1,477
2015 Q1 1.03B $47.6B -$628M $46.33 1,459
2014 Q4 1.04B $46.9B +$462M $45.02 1,466
2014 Q3 1.03B $42.7B +$362M $41.59 1,384
2014 Q2 1.02B $41.7B +$96.9M $40.90 1,382
2014 Q1 1.02B $39.3B -$1.21B $38.51 1,367